Search

Search Constraints

You searched for: Author/Creator Hidaka, Hisashi

Search Results

1. Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis. Issue 2 (5th January 2021)

2. Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double‐blind, controlled trial. Issue 3 (7th August 2017)

3. Clinical outcomes of antithrombin III‐based therapy for patients with portal vein thrombosis: A retrospective, multicenter study. Issue 1 (4th October 2022)

4. Close correlation between urinary sodium excretion and response to tolvaptan in liver cirrhosis patients with ascites. Issue 3 (19th May 2016)

5. Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting. Issue 1 (17th December 2021)

6. Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography. Issue 9 (11th December 2014)

7. Effect of branched-chain amino acid supplements on muscle strength and muscle mass in patients with liver cirrhosis. Issue 12 (December 2017)

8. Evidence‐based clinical practice guidelines for liver cirrhosis 2020. Issue 7 (6th July 2021)

9. FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma1. Issue 4 (11th February 2013)

10. Field practice study of half‐dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis. Issue 3 (28th May 2014)